8-K

Company

Royalty Pharma plc

Filed

June 4, 2024

Period of Report

June 3, 2024

Accession Number

0001193125-24-154347

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →